Australia markets closed

Valneva SE (INRLF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.82000.0000 (0.00%)
At close: 03:12PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate

    Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the the safety and immunogenicity of VLA1601, its second-generation adjuvanted inactivated vaccine candidate against the Zika virus (ZIKV). There are currently no preventive vaccines or effective treatments available against ZIKV. As such, this mosquito-borne disease remains a public health threat and is i

  • GlobeNewswire

    Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F

    Saint-Herblain (France), March 25, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 22, 2024, of its 2023 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing number D.24-0157 and its Form 20-F with the U.S. Securities and Exchange Commission (SEC). Valneva’s 2023 Universal Registration Document – available in its entirety in French – includes the Company’s 2023 Annual Fina

  • Insider Monkey

    Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript

    Valneva SE (NASDAQ:VALN) Q4 2023 Earnings Call Transcript March 20, 2024 Valneva SE misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $0.2. VALN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Joshua Drumm: Thank you. Hello, and thank […]